COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 01:00, il y a 1 année 7 mois Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options Onco-Innovations Limited announces exclusive-licensed PNKP inhibitors Technology targeting cancer cells to enhance treatment effectiveness across various cancer types including colorectal, breast, and lung cancer Clinical Trials Cancer Treatment Oncology Market Onco-Innovations Limited PNKP Inhibitors Technology
Publié le 18/08/2026 à 18:00, il y a 4 jours 1 heure KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Publié le 18/08/2026 à 17:45, il y a 4 jours 1 heure Mise à disposition du rapport financier annuel 2025-26
Publié le 22/08/2026 à 05:50, il y a 13 heures 20 minutes Battery X Metals Provides Board of Directors Update
Publié le 22/08/2026 à 04:55, il y a 14 heures 15 minutes Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Publié le 22/08/2026 à 00:30, il y a 18 heures 40 minutes BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Publié le 21/08/2026 à 23:00, il y a 20 heures 10 minutes Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Publié le 21/08/2026 à 23:00, il y a 20 heures 10 minutes Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott
Publié le 21/08/2026 à 19:36, il y a 23 heures 34 minutes EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Publié le 21/08/2026 à 19:11, il y a 23 heures 59 minutes EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Publié le 21/08/2026 à 17:27, il y a 1 jour 1 heure EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Publié le 21/08/2026 à 16:30, il y a 1 jour 2 heures BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
